Blog - Pharmacist Digest

Live blog: Tracking the meeting of the FDA advisory panel on Covid vaccines

STAT

JANUARY 26, 2023

Fasten your seat belts, folks. We’re about to hit some turbulence. If you’re reading this, you’re interested in the discussion on the future of Covid-19 vaccination that’s going to take place today in a meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.

Vaccines

STAT+: What’s an AI scaling law? We’ve found biology’s, says Profluent

STAT

APRIL 23, 2025

The headline takeaway from the company’s blog post and preprint is that Profluent says it’s discovered AI scaling laws for biology. Frizzle would say , “Seatbelts, everyone!” ” Last week, AI protein design startup Profluent released a new, more powerful model called ProGen3.

Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about

STAT

JULY 8, 2023

This essay was originally published on Gideon Meyerowitz-Katz’s Medium blog. A spartame is an artificial sweetener that is used in a lot of products, including Diet Coke and Coke Zero. Like most artificial sweeteners, we have a wonderful love/hate relationship with it.

STAT+: DeepMind launches AlphaGenome, aiming to predict gene regulation from DNA sequence

STAT

JUNE 25, 2025

In a preprint and blog post published on Wednesday, it announced its latest stab at the challenge with a new model called AlphaGenome, an early step toward possible applications in therapeutic development. But DeepMind has lately been working on a much gnarlier precursor problem: predicting how DNA encodes gene regulation.

Guest Blog: From Eye Patches to Indie Films: How Pop Culture Can Spark Conversations About Children’s Vision Health

Putting Patients First Blog

JUNE 5, 2025

Guest Blog: From Eye Patches to Indie Films: How Pop Culture Can Spark Conversations About Children’s Vision Health June 5, 2025 By: Jeff Todd, President & CEO, Prevent Blindness We know that pop culture can shape public conversations. Memes and headlines spark cultural touchpoints and can make complex health topics more relatable.

Diabetes

STAT+: Student group that ranked med schools over industry conflicts votes to accept pharma funding

STAT

JUNE 5, 2024

There are restrictions, though. Funding must align with AMSA goals or provide “unique educational value without direction or conditions.”

STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity

STAT

JANUARY 27, 2024

PONTYPRIDD, Wales — The blog post that has shaken the leadership of Boston’s Dana-Farber Cancer Institute, one of the world’s preeminent cancer research centers, was written some 3,000 miles away, in a bare-walled, sparsely decorated flat, save for a stack of statistics books and a collection of Rubik’s Cubes.

STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD

STAT

JUNE 4, 2024

Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for MDMA-assisted psychotherapy to treat post-traumatic stress disorder. The discussion will start at 8:30 a.m. ET and run until about 5:30 p.m. here’s an agenda ).

STAT+: Dana-Farber retracts string of studies in systematic review of data integrity

STAT

APRIL 18, 2024

The issues with this paper, along with concerns with more than 50 other articles co-authored by four of Dana-Farber’s top researchers, were highlighted in a January blog post by the scientific sleuth Sholto David.

STAT+: Cigna, Humana in talks to merge into health insurance giant, per report

STAT

NOVEMBER 29, 2023

Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday. The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Continue to STAT+ to read the full story…

Drug Pricing

Turning Loss into Purpose: My Journey to a Pharmacy Career to Make a Difference

Pharmacy Is Right For Me

NOVEMBER 4, 2024

For those interested in a similarly fulfilling career in pharmacy, check out the Pharm4Me website for valuable information on becoming a pharmacist, and read more inspirational stories on the Pharm4Me Blog. The post Turning Loss into Purpose: My Journey to a Pharmacy Career to Make a Difference appeared first on Pharmacy for me.

STAT+: Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money

STAT

OCTOBER 17, 2022

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting. Continue to STAT+ to read the full story…

STAT+: FDA advisory panel narrowly recommends approval for Sarepta’s gene therapy for Duchenne

STAT

MAY 12, 2023

For an archived version of a live blog about Friday’s FDA advisory panel hearing, click here.

EM Match Advice 46 | Program Directors Share Match Season Insights

ALiEM - Pharm Pearls

JANUARY 29, 2025

Read and Listen to the Other EM Match Advice Episodes Blog posts: [link] Author information Sara M. Focus on creating a rank list that reflects your true preferences rather than trying to predict where programs might rank you. Trust your instincts and prioritize what matters most to you in your training journey.

Communication

Communication Hospitals

Operation Warp Speed but for rare disease

STAT

JUNE 4, 2024

Our reporters Olivia Goldhill and Meghana Keshavan will be live-blogging the meeting all day — tune in here. It’s a critical meeting — MDMA could be the first Schedule I psychedelic to be deemed to have a medical use. Read the rest…

Drug Pricing

Drug Pricing Drug Development

ALiEM AIR Series | Trauma 2023 Module

ALiEM - Pharm Pearls

NOVEMBER 3, 2023

8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. More specifically, we identified 3 AIR and 5 Honorable Mentions. Ann Emerg Med. 2023;82(1):55-65.

Labelling

ALiEM AIR Series | Toxicology Module

ALiEM - Pharm Pearls

FEBRUARY 5, 2024

8 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. More specifically, we identified 3 AIR and 5 Honorable Mentions. Please go to the above link.

What Could Changes in Tariff Policies Mean for Patients?

Putting Patients First Blog

MARCH 31, 2025

Other Blogs: What Could Changes in Tariff Policies Mean for Patients? 03/31/2025 Read More Guest Blog: Rewriting Womens History to a Healthier Her-story 03/27/2025 Read More Guest Blog: Navigating the AI Revolution: Patient-Centered AI Use in Health Care 03/24/2025 Read More The post What Could Changes in Tariff Policies Mean for Patients?

EM Match Advice 44: Approaching your EM sub-internship clerkship – “Just gotta roll with it”

ALiEM - Pharm Pearls

JUNE 25, 2024

Podcast: Approaching your EM Sub-Internship Clerkship Mentioned Links CDEM Medical Student Curriculum Emergency Ultrasound Teaching Read and Listen to the Other EM Match Advice Episodes Blog posts: [link] Author information Sara M.

Patient-Centric Approaches to Maintaining Brand Value

Drug Patent Watch

APRIL 9, 2025

In our latest blog post, we explore the importance of putting patients first in brand strategy. Patient-Centric Approaches to Maintaining Brand Value As the pharmaceutical industry continues to evolve, one thing remains clear: patients are at the forefront of every decision.

Introducing the Uniform Version of the MPJE

National Association of Boards of Pharmacy

APRIL 16, 2025

In our last blog post, we discussed the development and the recent improvements that have been made to the MPJE and its purpose: to evaluate candidates understanding and application of federal and state-specific laws and regulations. Read about the MPJE in Part 1 of this blog post.

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

MARCH 5, 2025

Learn more about the science and art of pharmaceutical drug naming in our latest blog post: [link] What do you think is the most challenging aspect of pharmaceutical drug naming? Share your thoughts in the comments below!

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Dosage Labelling

Tamsulosin Versus Alfuzosin – What Pharmacists Need to Know

Med Ed 101

JULY 13, 2025

In this blog post, we will compare tamsulosin versus alfuzosin. Tamsulosin and alfuzosin both act on the sympathetic nervous system. Tamsulosin and alfuzosin both work as Alpha1 antagonists. More specifically, tamsulosin targets the Alpha1A receptor subtype. Both medications are typically dosed once daily.

ALiEM AIR Series | Respiratory 2023 Module

ALiEM - Pharm Pearls

OCTOBER 14, 2023

6 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. More specifically, we identified 3 AIR and 3 Honorable Mentions. Ann Emerg Med. 2023;82(1):55-65.

Labelling

Labelling Hospitals

Rise of almost untreatable superbug linked to a common antibiotic

The Guardian - Pharmaceutical Industry

OCTOBER 23, 2024

‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led (..)

The Global Generic Drug Market: Trends, Opportunities, and Challenges

Drug Patent Watch

MARCH 31, 2025

To learn more about the global generic drug market, including its trends, opportunities, and challenges, check out our latest blog post: [link] What do you think is the most significant challenge facing the global generic drug market? Share your thoughts in the comments below.

Generic Drug Development: Avoid These Common Pitfalls

Drug Patent Watch

APRIL 24, 2025

Check out our latest blog post to learn how to avoid the most common mistakes in generic drug development: [link] From patent strategies to regulatory hurdles, we break down the key takeaways to help you navigate the complex landscape of generic drug development and bring your product to market successfully. Don't let this happen to you.

Drug Development

LIFE SCIENCES | DAILY NEWS | JUN 11, 2025 | PHARMASHOTS

PharmaShots

JUNE 11, 2025

Skip to content Skip to footer NEWS TOP 20 INSIGHTS INSIGHTS+ THOUGHTSPOT INTERVIEWS VIEWPOINTS EXCLUSIVE SPOTLIGHT EVENTS MAGAZINE Subscribe Now NEWS TOP 20 INSIGHTS INSIGHTS+ THOUGHTSPOT INTERVIEWS VIEWPOINTS EXCLUSIVE SPOTLIGHT EVENTS MAGAZINE Login or Register Home Features Blog Page Blog Band Blog Standard Blog Classic Blog Classic with sidebar (..)

Biosimilars

How to Ensure Compliance in Generic Drug Development

Drug Patent Watch

APRIL 14, 2025

In our latest blog post, we dive into the key considerations for ensuring compliance in generic drug development. "Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies.

Drug Development

Drug Development Pharmaceutical Companies Pharmaceutical Companies

STAT+: Pharmalittle: We’re reading about an FDA meeting on MDMA, a new obesity pill, and more

STAT

JUNE 4, 2024

Follow the meeting on the live STAT blog here. ” This follows a decades-long push by advocates who say drugs like MDMA can treat mental health disorders and have therapeutic applications beyond their illicit use. Continue to STAT+ to read the full story…

Drug Development

LIFE SCIENCES | DAILY NEWS | JUN 13, 2025 | PHARMASHOTS

PharmaShots

JUNE 13, 2025

Skip to content Skip to footer NEWS TOP 20 INSIGHTS INSIGHTS+ THOUGHTSPOT INTERVIEWS VIEWPOINTS EXCLUSIVE SPOTLIGHT EVENTS MAGAZINE Subscribe Now NEWS TOP 20 INSIGHTS INSIGHTS+ THOUGHTSPOT INTERVIEWS VIEWPOINTS EXCLUSIVE SPOTLIGHT EVENTS MAGAZINE Login or Register Home Features Blog Page Blog Band Blog Standard Blog Classic Blog Classic with sidebar (..)

Biosimilars

Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union

Quality Matters

APRIL 17, 2025

come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API). Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S.

Pharmaceutical Manufacturing

How to Be Successful on Your APPE Rotations?

UWorld | RxPrep

JULY 1, 2025

Share this blog July 1, 2025 Pharmacy School Quick Links Completing Advanced Pharmacy Practice Experiences (APPEs) is a pivotal step in your journey from pharmacy student to practicing professional. Share this blog Prev Previous Post Next Post Next Quick Links View More. Maximize your APPE pharmacy experience today.

Documentation

Documentation Patient Counseling Communication Inpatient

ALiEM AIR Series | Procedures Module

ALiEM - Pharm Pearls

APRIL 14, 2023

6 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. More specifically, we identified 2 AIR and 4 Honorable Mentions.

Labelling

Acyclovir Versus Valacyclovir – What’s the Difference?

Med Ed 101

MAY 7, 2025

In this blog post, I will highlight the most important differences […] The post Acyclovir Versus Valacyclovir – What’s the Difference? While both medications are effective, understanding their pharmacokinetic profiles, dosage forms, and clinical uses can help healthcare providers make the best choice for each patient.

Dosage

CPA honoured at the 2025 Antibiotic Guardian Awards!

Commonwealth Pharmacists Association

JUNE 20, 2025

You can read more about the work of this project by reading Nikki’s blog here. This award recognises the immense efforts of Dr Nikki D’Arcy and her team to advance microbiology within the CwPAMS Health Partnerships and beyond. It is an honour to be nominated and to have our work acknowledged.”

Communication

Communication Hospitals

STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India

STAT

NOVEMBER 1, 2023

Read STAT’s live blog of yesterday’s advisory committee meeting here. FDA staff said the new type of technology raised concerns about unintended genomic alterations that can potentially cause other side effects, but did not raise any concerns about efficacy.

Biosimilars

How counterfeiters are breaching India’s QR code system

Express Pharma

MAY 4, 2025

Writing for Express Pharma in two successive blog posts, Dr Avi Chaudhuri, a global expert on anticounterfeiting, gives details of how Sun Pharma seems to be the victim of digital leakage of QR codes, either from the code generating source (the vendor supplying the codes) or the code application site (Sun Pharmas plant in Assam).

Packaging

FDA Inspections: Lesson 1 – Interviewing Employees

FDA Law Blog: Biosimilars

JANUARY 9, 2025

Farquhar This is the first in a series of blog posts on tips for successfully handling an FDA inspection. Much of the debate on this issue centers on whether FDA can take photographs during an inspection (see our previous blog post ). Walsh & Hyman, Phelps & McNamara, P.C. & & Douglas B.

Documentation

Documentation Labelling

Identifying and Invalidating Weak Drug Patents in the United States

Drug Patent Watch

APRIL 29, 2025

Check out our latest blog post to learn how to identify and invalidate weak drug patents in the US: [link] Don't let weak patents stand in the way of your business. At DrugPatentWatch, we've identified a staggering number of opportunities for generic manufacturers to invalidate these weak patents and bring affordable medications to market.

EM Match Advice 45: 2024 MyERAS Updates– What EM Applicants Need to Know

ALiEM - Pharm Pearls

AUGUST 19, 2024

Tips for the personal statement Mentioned Resources CORD website: New MyERAS® Application: Guidance for Emergency Medicine Read and Listen to the Other EM Match Advice Episodes Blog posts: [link] Author information Sara M.

Reimagining Pharmacy Workforce Development: The CPA Academy

Commonwealth Pharmacists Association

JUNE 30, 2025

Here, she led the Education Delivery Strategy, including a partnership with the Royal College of General Practitioners to deliver England’s Community Pharmacist Consultation Service Training programme, the multi-professional Joint Royal College Medication Safety Education Series, and the RPS’ Annual Conference and events programme.

Health and Personal Care Stores

Health and Personal Care Stores Communication Diabetes

Why Most Pharmacy Graduates Test in the Summer?

UWorld | RxPrep

JULY 1, 2025

Share this blog July 1, 2025 Pharmacy School Quick Links Why Is Fresh Knowledge After Graduation So Valuable? Share this blog Prev Previous Post Quick Links View More. Latest From the UWorld Pharmacy Blog Pharmacy School How to Be Successful on Your APPE Rotations? Try These Study Hacks!

Federal District Court Vacates FDA’s Laboratory Developed Tests Final Rule

FDA Law Blog: Biosimilars

MARCH 31, 2025

Expect another blog from us in the coming days that will provide a more detailed discussion of what this decision means for healthcare practitioners, the laboratory industry, and the public. Laposata were represented by a team at Hyman, Phelps & McNamara, P.C.,

Live blog: Tracking the meeting of the FDA advisory panel on Covid vaccines

STAT+: What’s an AI scaling law? We’ve found biology’s, says Profluent

Trending Sources

Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about

STAT+: DeepMind launches AlphaGenome, aiming to predict gene regulation from DNA sequence

Guest Blog: From Eye Patches to Indie Films: How Pop Culture Can Spark Conversations About Children’s Vision Health

STAT+: Student group that ranked med schools over industry conflicts votes to accept pharma funding

STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity

STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD

STAT+: Dana-Farber retracts string of studies in systematic review of data integrity

STAT+: Cigna, Humana in talks to merge into health insurance giant, per report

Turning Loss into Purpose: My Journey to a Pharmacy Career to Make a Difference

STAT+: Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money

STAT+: FDA advisory panel narrowly recommends approval for Sarepta’s gene therapy for Duchenne

EM Match Advice 46 | Program Directors Share Match Season Insights

Operation Warp Speed but for rare disease

ALiEM AIR Series | Trauma 2023 Module

ALiEM AIR Series | Toxicology Module

What Could Changes in Tariff Policies Mean for Patients?

EM Match Advice 44: Approaching your EM sub-internship clerkship – “Just gotta roll with it”

Patient-Centric Approaches to Maintaining Brand Value

Introducing the Uniform Version of the MPJE

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Tamsulosin Versus Alfuzosin – What Pharmacists Need to Know

ALiEM AIR Series | Respiratory 2023 Module

Rise of almost untreatable superbug linked to a common antibiotic

The Global Generic Drug Market: Trends, Opportunities, and Challenges

Generic Drug Development: Avoid These Common Pitfalls

LIFE SCIENCES | DAILY NEWS | JUN 11, 2025 | PHARMASHOTS

How to Ensure Compliance in Generic Drug Development

STAT+: Pharmalittle: We’re reading about an FDA meeting on MDMA, a new obesity pill, and more

LIFE SCIENCES | DAILY NEWS | JUN 13, 2025 | PHARMASHOTS

Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union

How to Be Successful on Your APPE Rotations?

ALiEM AIR Series | Procedures Module

Acyclovir Versus Valacyclovir – What’s the Difference?

CPA honoured at the 2025 Antibiotic Guardian Awards!

STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India

How counterfeiters are breaching India’s QR code system

FDA Inspections: Lesson 1 – Interviewing Employees

Identifying and Invalidating Weak Drug Patents in the United States

EM Match Advice 45: 2024 MyERAS Updates– What EM Applicants Need to Know

Reimagining Pharmacy Workforce Development: The CPA Academy

Why Most Pharmacy Graduates Test in the Summer?

Federal District Court Vacates FDA’s Laboratory Developed Tests Final Rule

Stay Connected